In conclusion, in this study of a pediatric population, rhC1‐INH 50 IU/kg (maximum, 4200 IU) was efficacious, safe, and well tolerated in treating HAE attacks in children with C1‐INH‐HAE. This evidence concerns the gene SERPING1 and hereditary angioedema.